
Sign up to save your podcasts
Or


In this week’s View, Dr. Eagle discusses P2Y12 inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions, then looks at practical approaches to genetic screening in cardiomyopathies. Finally, Dr. Eagle explores long-term outcomes of perioperative myocardial infarction or injury after non-cardiac surgery.
Subscribe to Eagle’s Eye View
By American College of Cardiology4.7
129129 ratings
In this week’s View, Dr. Eagle discusses P2Y12 inhibitor monotherapy or dual antiplatelet therapy after complex percutaneous coronary interventions, then looks at practical approaches to genetic screening in cardiomyopathies. Finally, Dr. Eagle explores long-term outcomes of perioperative myocardial infarction or injury after non-cardiac surgery.
Subscribe to Eagle’s Eye View

134 Listeners

321 Listeners

504 Listeners

167 Listeners

906 Listeners

298 Listeners

1,150 Listeners

65 Listeners

39 Listeners

194 Listeners

94 Listeners

367 Listeners

437 Listeners

375 Listeners

32 Listeners